Delsym (Dextromethorphan)
- Product NDC
- 63824-177
- 11-digit product format
- 638240177
- Labeler code
- 63824
- Product ID
- 63824-177_51b62d53-491c-8ba5-e063-6394a90a1821
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Dextromethorphan
- Dosage form
- SUSPENSION, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Reckitt Benckiser LLC
- Application
- NDA018658
- Marketing category
- NDA
- Marketing start
- 2011-08-19
- Substance
- DEXTROMETHORPHAN
- Active strength
- 30 mg/5mL
- Pharmacologic classes
- Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 63824-177 | 63824-177-65 | D | Discontinued by firm | 2026-08-17 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Code | Status | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 63824-177-65 | D | Discontinued by firm | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 63824-177-65 | D | Discontinued by firm | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 63824-177-65 | D | Discontinued by firm | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 63824-177-65 | D | Discontinued by firm | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 63824-177-65 | D | Discontinued by firm | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 63824-177-65 | D | Discontinued by firm | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 63824-177-65 | D | Discontinued by firm | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 63824-177-65 | D | Discontinued by firm | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 63824-177-65 | D | Discontinued by firm | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 63824-177-65 | D | Discontinued by firm | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 63824-177-65 | D | Discontinued by firm | 367a005e9d99… | 383a685ebd0f… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded product | product | I | Inactivated by FDA | 86f5da6cb304… | a595104c45d7… | |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 63824-177-65 | I | Inactivated by FDA | 86f5da6cb304… | a595104c45d7… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 63824-177-63 | I | Inactivated by FDA | 86f5da6cb304… | a595104c45d7… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded product | product | I | Inactivated by FDA | bd6a592717d7… | 303034d00443… | |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 63824-177-65 | I | Inactivated by FDA | bd6a592717d7… | 303034d00443… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 63824-177-63 | I | Inactivated by FDA | bd6a592717d7… | 303034d00443… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N018658-001 | DELSYM | DEXTROMETHORPHAN POLISTIREX | EQ 30MG HYDROBROMIDE/5ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 1982-10-08 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N018658-001 | DELSYM | EQ 30MG HYDROBROMIDE/5ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 1982-10-08 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N018658-001 | DELSYM | EQ 30MG HYDROBROMIDE/5ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 1982-10-08 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N018658-001 | DELSYM | EQ 30MG HYDROBROMIDE/5ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 1982-10-08 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N018658-001 | DELSYM | EQ 30MG HYDROBROMIDE/5ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 1982-10-08 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N018658-001 | DELSYM | EQ 30MG HYDROBROMIDE/5ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 1982-10-08 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N018658-001 | DELSYM | EQ 30MG HYDROBROMIDE/5ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 1982-10-08 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N018658-001 | DELSYM | EQ 30MG HYDROBROMIDE/5ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 1982-10-08 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N018658-001 | DELSYM | EQ 30MG HYDROBROMIDE/5ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 1982-10-08 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N018658-001 | DELSYM | EQ 30MG HYDROBROMIDE/5ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 1982-10-08 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N018658-001 | DELSYM | EQ 30MG HYDROBROMIDE/5ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 1982-10-08 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N018658-001 | DELSYM | EQ 30MG HYDROBROMIDE/5ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 1982-10-08 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N018658-001 | DELSYM | EQ 30MG HYDROBROMIDE/5ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 1982-10-08 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N018658-001 | DELSYM | EQ 30MG HYDROBROMIDE/5ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 1982-10-08 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N018658-001 | DELSYM | EQ 30MG HYDROBROMIDE/5ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 1982-10-08 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N018658-001 | DELSYM | EQ 30MG HYDROBROMIDE/5ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 1982-10-08 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N018658-001 | DELSYM | EQ 30MG HYDROBROMIDE/5ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 1982-10-08 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N018658-001 | DELSYM | EQ 30MG HYDROBROMIDE/5ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 1982-10-08 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N018658-001 | DELSYM | EQ 30MG HYDROBROMIDE/5ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 1982-10-08 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N018658-001 | DELSYM | EQ 30MG HYDROBROMIDE/5ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 1982-10-08 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N018658-001 | DELSYM | EQ 30MG HYDROBROMIDE/5ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 1982-10-08 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N018658-001 | DELSYM | EQ 30MG HYDROBROMIDE/5ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 1982-10-08 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N018658-001 | DELSYM | EQ 30MG HYDROBROMIDE/5ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 1982-10-08 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N018658-001 | DELSYM | EQ 30MG HYDROBROMIDE/5ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 1982-10-08 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N018658-001 | DELSYM | EQ 30MG HYDROBROMIDE/5ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 1982-10-08 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N018658-001 | DELSYM | EQ 30MG HYDROBROMIDE/5ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 1982-10-08 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N018658-001 | DELSYM | EQ 30MG HYDROBROMIDE/5ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 1982-10-08 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N018658-001 | DELSYM | EQ 30MG HYDROBROMIDE/5ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 1982-10-08 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N018658-001 | DELSYM | EQ 30MG HYDROBROMIDE/5ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 1982-10-08 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N018658-001 | DELSYM | EQ 30MG HYDROBROMIDE/5ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 1982-10-08 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N018658-001 | DELSYM | EQ 30MG HYDROBROMIDE/5ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 1982-10-08 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N018658-001 | DELSYM | EQ 30MG HYDROBROMIDE/5ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 1982-10-08 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N018658-001 | DELSYM | EQ 30MG HYDROBROMIDE/5ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 1982-10-08 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N018658-001 | DELSYM | EQ 30MG HYDROBROMIDE/5ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 1982-10-08 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N018658-001 | DELSYM | EQ 30MG HYDROBROMIDE/5ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 1982-10-08 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N018658-001 | DELSYM | EQ 30MG HYDROBROMIDE/5ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 1982-10-08 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N018658-001 | DELSYM | EQ 30MG HYDROBROMIDE/5ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 1982-10-08 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N018658-001 | DELSYM | EQ 30MG HYDROBROMIDE/5ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 1982-10-08 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N018658-001 | DELSYM | EQ 30MG HYDROBROMIDE/5ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 1982-10-08 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | N018658-001 | DELSYM | EQ 30MG HYDROBROMIDE/5ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 1982-10-08 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | N018658-001 | DELSYM | EQ 30MG HYDROBROMIDE/5ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 1982-10-08 | e64feba35796… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Delsym (Dextromethorphan)
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| DEXTROMETHORPHAN | 30 mg/5mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 7355X3ROTS | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| ce4b477c-430e-40a3-b247-b3914ef17793 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| bf324df6-7127-7deb-def5-2681c136cd03 | Product name | 3 | 20250325 |
| 362d7abb-94e6-4c60-9a58-266894157713 | Product name | 1 | 20231023 |
| 43a1ed49-eae2-4840-8075-cb4b33478540 | Product name | 1 | 20230425 |
| ba088a92-ab5e-b2d4-e908-f5ea691b7587 | Product name | 7 | 20210201 |
| 816b97af-edc5-4060-aff1-b814bdbcad50 | Product name | 1 | 20190415 |
| 419aab54-5d5a-4146-9453-026d4a9991be | Product name | 2 | 20170525 |
| 89dac932-b90a-4410-9ab1-84c53e57de25 | Product name | 1 | 20150316 |
| 76633df9-0d59-4b88-03ed-21dee1b966f8 | Product name | 1 | 20140508 |
| d723478e-ad4a-ec23-6bd7-cfe33e1e3840 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 63824-177-63 | 2022-06-21 | Delsym ® (Dextromethorphan) Suspension Extended-Release |
| 63824-177-65 | 2022-06-21 | Delsym ® (Dextromethorphan) Suspension Extended-Release |
| 63824-177-63 | 2022-01-28 | Delsym ® (Dextromethorphan) Suspension Extended-Release |
| 63824-177-65 | 2022-01-28 | Delsym ® (Dextromethorphan) Suspension Extended-Release |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63824-177-63 | Delsym (Dextromethorphan) | 89 mL in 1 BOTTLE | SUSPENSION, EXTENDED RELEASE | 89 | 8 | |
| 63824-177-63 | Delsym (Dextromethorphan) | 1 in 1 CARTON | SUSPENSION, EXTENDED RELEASE | 1 | 8 | |
| 63824-177-65 | Delsym (Dextromethorphan) | 148 mL in 1 BOTTLE | SUSPENSION, EXTENDED RELEASE | 148 | 8 | |
| 63824-177-65 | Delsym (Dextromethorphan) | 1 in 1 CARTON | SUSPENSION, EXTENDED RELEASE | 1 | 8 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63824-177-63 | ML - Milliliter | 63824-177 | 89c18b57-1a96-4537-a71a-61fad394a8d5 | 1 | 2015-10-02 |
| 63824-177-65 | ML - Milliliter | 63824-177 | 72949293-23a2-477c-ba6b-9e5568dcf5cf | 1 | 2015-10-02 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Delsym | DEXTROMETHORPHAN | Reckitt Benckiser LLC | 234e6a2c-a280-4a39-8777-9316e9d681fb | 2026-05-27 | Warnings | 018658 NDA018658 |
| Delsym | DEXTROMETHORPHAN | Reckitt Benckiser LLC | e3e1d126-76c2-4776-8ce0-449625b7e6ba | 2026-05-27 | Warnings | 018658 NDA018658 |
| Delsym (Dextromethorphan) | DEXTROMETHORPHAN | Reckitt Benckiser LLC | bb0116d0-93e4-44e2-b0e4-c0b773eced6f | 2026-05-20 | Warnings | 018658 NDA018658 |
| Delsym (Dextromethorphan) | DEXTROMETHORPHAN | Reckitt Benckiser LLC | ce4b477c-430e-40a3-b247-b3914ef17793 | 2026-05-13 | Warnings | 018658 NDA018658 63824-177 |
| DELSYM | DEXTROMETHORPHAN | A-S Medication Solutions | 2ac3cac7-5980-4ff5-9939-d494c3daa9d2 | 2025-02-28 | Warnings | 018658 NDA018658 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1373128 | Delsym 30 MG in 5 mL 12HR Extended Release Oral Suspension | PSN | ce4b477c-430e-40a3-b247-b3914ef17793 | 8 |
| 1373045 | dextromethorphan polistirex 30 MG in 5 mL 12HR Extended Release Oral Suspension | PSN | ce4b477c-430e-40a3-b247-b3914ef17793 | 8 |
| 1373128 | 12 HR dextromethorphan polistirex 6 MG/ML Extended Release Suspension [Delsym] | SBD | ce4b477c-430e-40a3-b247-b3914ef17793 | 8 |
| 1373045 | 12 HR dextromethorphan polistirex 6 MG/ML Extended Release Suspension | SCD | ce4b477c-430e-40a3-b247-b3914ef17793 | 8 |
| 1373128 | Delsym (dextromethorphan polistirex equivalent to 30 mg per 5 ML dextromethorphan hydrobromide) 12 HR Extended Release Suspension | SY | ce4b477c-430e-40a3-b247-b3914ef17793 | 8 |
| 1373045 | dextromethorphan polistirex (dextromethorphan HBr 30 MG) per 5 ML 12 HR Extended Release Suspension | SY | ce4b477c-430e-40a3-b247-b3914ef17793 | 8 |
| 1373045 | dextromethorphan polistirex 6 MG/ML 12 HR Extended Release Suspension | SY | ce4b477c-430e-40a3-b247-b3914ef17793 | 8 |
| 1373128 | Delsym 30 MG in 5 mL 12HR Extended Release Oral Suspension | PSN | 56f5f9d1-54a6-48a5-8033-efc29e632479 | 2 |
| 1373045 | dextromethorphan polistirex 30 MG in 5 mL 12HR Extended Release Oral Suspension | PSN | 56f5f9d1-54a6-48a5-8033-efc29e632479 | 2 |
| 1373128 | 12 HR dextromethorphan polistirex 6 MG/ML Extended Release Suspension [Delsym] | SBD | 56f5f9d1-54a6-48a5-8033-efc29e632479 | 2 |
| 1373045 | 12 HR dextromethorphan polistirex 6 MG/ML Extended Release Suspension | SCD | 56f5f9d1-54a6-48a5-8033-efc29e632479 | 2 |
| 1373128 | Delsym (dextromethorphan polistirex equivalent to 30 mg per 5 ML dextromethorphan hydrobromide) 12 HR Extended Release Suspension | SY | 56f5f9d1-54a6-48a5-8033-efc29e632479 | 2 |
| 1373045 | dextromethorphan polistirex (dextromethorphan HBr 30 MG) per 5 ML 12 HR Extended Release Suspension | SY | 56f5f9d1-54a6-48a5-8033-efc29e632479 | 2 |
| 1373045 | dextromethorphan polistirex 6 MG/ML 12 HR Extended Release Suspension | SY | 56f5f9d1-54a6-48a5-8033-efc29e632479 | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 63824-177-63 | 63824017763 | 1 BOTTLE in 1 CARTON (63824-177-63) / 89 mL in 1 BOTTLE | 1 bottle | 2011-08-19 | 0000-00-00 | No | No | Current |
| 63824-177-65 | 63824017765 | 1 BOTTLE in 1 CARTON (63824-177-65) > 148 mL in 1 BOTTLE | 1 bottle | 2017-07-01 | 0000-00-00 | No | No | Current |